METHOD OF PREDICTING fatty liver disease in patients with chronic hepatitis C

摘要

A method of predicting the development of fatty liver disease in patients with chronic hepatitis C virus by examining the patient's blood serum, characterized in that further in the serum of the patient define apolipoprotein A-1 and apo B-100 in the dynamics and high levels of apolipoprotein B-100 (1.15 g / l at a rate of up to 0.94 g / l) and low levels of apolipoprotein A-1 (0.92 at a rate of 1.59 g / l) indicates the highest to 85% risk of developing fatty liver disease in patients with chronic hepatitis C. .